Lundbeck divests preclinical research programs Two programs outside Lundbeck’s areas of focus are transferred to MindImmune Therapeutics, Inc. H. Lundbeck A/S (Lundbeck) further focuses its preclinical research pipeline with the divestment of two research programs...